These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9685943)

  • 1. Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF).
    Gibaud S; Rousseau C; Weingarten C; Favier R; Douay L; Andreux JP; Couvreur P
    J Control Release; 1998 Mar; 52(1-2):131-9. PubMed ID: 9685943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeting bone marrow with the help of polyalkylcyanoacrylate nanoparticles].
    Gibaud S; Weingarten C; Andreux JP; Couvreur P
    Ann Pharm Fr; 1999 Jul; 57(4):324-31. PubMed ID: 10472705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
    Huang W; Liu J; Zeng Y; Wu F; Li N; Chen K; Hong Y; Wang L; Zhen H; Lin L
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):607-613. PubMed ID: 30043207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
    Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
    Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long survival of leukemic mice by repeated combination treatment of cyclophosphamide and recombinant human granulocyte colony-stimulating factor.
    Tamura M; Nomura H; Ono M; Bessho M; Hirashima K
    Leukemia; 1991 Dec; 5(12):1043-9. PubMed ID: 1723131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
    Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
    Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
    Matsuzaki G; Li XY; Ohyama Y; Nomoto K
    Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of a novel recombinant human granulocyte colony-stimulating factor in rats.
    Liu XX; Jiang YP
    Chin Med Sci J; 2010 Mar; 25(1):13-9. PubMed ID: 20449948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by polyethylene glycol on anticancer drug-induced neutropenia in mice.
    Ishikawa M; Okada Y; Satake-Ishikawa R; Kakitani M; Kawagishi M; Matsuki S; Kusaka M; Asano K
    Gen Pharmacol; 1994 May; 25(3):533-7. PubMed ID: 7523237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant protein of recombinant human granulocyte colony-stimulating factor for receptor binding assay.
    Watanabe M; Fukamachi H; Uzumaki H; Kabaya K; Tsumura H; Ishikawa M; Matsuki S; Kusaka M
    Anal Biochem; 1991 May; 195(1):38-44. PubMed ID: 1716070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
    Misaki M; Ueyama Y; Tsukamoto G; Matsumura T
    Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
    Nagler A; Ginzton N; Negrin R; Bang D; Donlon T; Greenberg P
    Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro.
    Katayama K; Koizumi S; Ueno Y; Ohno I; Ichihara T; Horita S; Miyawaki T; Taniguchi N
    Exp Hematol; 1990 Jun; 18(5):390-4. PubMed ID: 1692536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
    Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y; Ohe Y
    Eur J Cancer; 1994; 30A(2):188-94. PubMed ID: 7512356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
    Tanaka H; Kaneko T
    Drug Metab Dispos; 1991; 19(1):200-4. PubMed ID: 1708329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia.
    Bernini JC; Wooley R; Buchanan GR
    J Pediatr; 1996 Oct; 129(4):551-8. PubMed ID: 8859262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
    Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
    Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.